Page 19 - Thyrocare Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sensex makes a U-turn to end 244 pts lower as bulls stare at Covid 2.0 restrictions SECTIONS Sensex makes a U-turn to end 244 pts lower as bulls stare at Covid 2.0 restrictionsBy Share Synopsis Dalal Street failed to hold on to early gains due to weak global cues and the possibility of a stricter lockdown in Maharashtra, said an analyst. The S&P BSE Sensex index traded in a range of 1,040 points during the day. Related NEW DELHI: Domestic equity benchmarks continued to show volatile moves on Tuesday as the government’s 'vaccine for all' announcement cheered investors but doubts over the co...

Dr A Velumani, managing director of Thyrocare Technologies talks of the hold up in testing and why the problem is universal. What is happening with the availability of testing kits? Reports suggest there is a huge shortage of RT-PCR kits, is that true? Is there enough capacity right now to fulfil the obligation of having 70% of all tests be RT-PCR in the state? There is no shortage of reagents, what is probably happening is that there is no more capacity. What that means is that laboratories are at their total capacity. If a city like Mumbai has the capacity to do 50,000 tests a day and dem...

COVID-19 test labs across the country are at their limits, says Thyrocare Tech MD, Dr Velumani SECTIONS Last Updated: Apr 14, 2021, 12:56 PM IST Share Synopsis We came down to as little as 20% capacity in January, but, in these last eight weeks there has been 100% growth, every week. Amidst these rising loads, we cannot do more, without more people, says Dr Velumani. Agencies Dr A Velumani, managing director of Thyrocare Technologies talks of the hold up in testing and why the problem is universal. What is happening with the availability of testing kits? Reports suggest there is a huge shor...

Hopes of more vaccine approvals send Sensex rebounding after its worst day in 6 weeks SECTIONS Share Benchmark indices Sensex and Nifty partially recovered sharp losses in the previous session. The S&P BSE Sensex index surged 744.05 points or 1.55% to touch 48,627.43 at the strongest level of the day. Related NSE Explore Now NEW DELHI: As soon as stock market bulls got a whiff of likely more vaccine approvals in the coming days that would reduce the possibility of lockdowns, benchmark indices surged on Tuesday, partly recovering sharp losses in the previous session. The market saw a partial...

Investors poorer by Rs 8.69 lakh crore as Covid 2.0 spooks D-Street bulls SECTIONS Share Synopsis Further imposition of lockdowns and all-time high Covid-19 cases have dragged the market to a monthly low. The S&P BSE Sensex index tumbled 1,897.88 points or 3.82% to hit 47,693.44 at the weakest level during the session. Related NSE Explore Now NEW DELHI: As India recorded its highest ever surge in new Covid-19 cases, investors dumped whatever they could get their hands on, pushing benchmark indices downhill on Monday. A weakening rupee also made Dalal Street equities unattractive. Further i...